Altre lingue Accuray Incorporated

Azioni

ARAY

US0043971052

Tempo reale stimato Cboe BZX Altri mercati azionari 19:17:01 30/04/2024			Variaz. 5gg	Var. 1 gen.
2,165 ^USD	-2,48%		-2,48%	-23,50%

25/04	Accuray Incorporated presenta i progressi delle soluzioni per la radioterapia progettati per migliorare l'esperienza di trattamento del cancro a ESTRO 2024	CI
18/04	Accuray Incorporated espande la rete globale di centri di formazione con l'apertura di una nuova struttura a Genolier, Svizzera	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024	25/04
Accuray Incorporated Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024	25/04
Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland	18/04
Accuray Incorporated Expands Global Training Center Network with Opening of New Facility in Genolier, Switzerland	18/04
Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024	17/04
New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System	26/03
Accuray Incorporated Announces New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can Be Effectively Treated in 5 Days Using the Accuray CyberKnife System	26/03
Accuray Incorporated to Speak at 36th Annual Roth Conference	04/03
Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference	27/02
Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System	13/02
Quebec Cancer Center Is First in Canada to Treat Cancer Patients Using the Accuray Radixact System	13/02
The Royal Marsden set to be the first center in the world to implement online adaptive radiation therapy utilizing ARTemis from RaySearch	08/02
Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	05/02
Accuray: Fiscal Q2 Earnings Snapshot	31/01
Earnings Flash (ARAY) ACCURAY INCORPORATED Posts Q2 Revenue $107.2M, vs. Street Est of $106.7M	31/01
Accuray Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	31/01
Accuray Incorporated Reaffirms Revenue Guidance for the Third Quarter and Full Fiscal Year 2024	31/01
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions	25/01
Accuray Incorporated Announces the Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray Cyberknife System	25/01
Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024	16/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Accuray Incorporated

Azioni

ARAY

US0043971052

Altre lingue

Filtri